Mizuho Securities USA LLC Acquires 2,960 Shares of STERIS plc (NYSE:STE)

Mizuho Securities USA LLC raised its stake in shares of STERIS plc (NYSE:STE - Free Report) by 46.3% in the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 9,355 shares of the medical equipment provider's stock after purchasing an additional 2,960 shares during the period. Mizuho Securities USA LLC's holdings in STERIS were worth $1,923,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors have also recently bought and sold shares of STE. Avalon Trust Co acquired a new position in shares of STERIS in the fourth quarter worth approximately $30,000. Human Investing LLC acquired a new position in shares of STERIS in the 4th quarter worth approximately $31,000. Anfield Capital Management LLC boosted its stake in shares of STERIS by 100.0% in the 4th quarter. Anfield Capital Management LLC now owns 182 shares of the medical equipment provider's stock valued at $37,000 after purchasing an additional 91 shares during the last quarter. Central Pacific Bank Trust Division increased its position in shares of STERIS by 65.5% during the fourth quarter. Central Pacific Bank Trust Division now owns 192 shares of the medical equipment provider's stock worth $39,000 after buying an additional 76 shares during the period. Finally, Manchester Capital Management LLC raised its stake in STERIS by 182.7% during the fourth quarter. Manchester Capital Management LLC now owns 212 shares of the medical equipment provider's stock worth $44,000 after buying an additional 137 shares during the last quarter. 94.69% of the stock is owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

A number of analysts have commented on the stock. Piper Sandler upped their price target on shares of STERIS from $260.00 to $265.00 and gave the company an "overweight" rating in a research report on Monday, February 3rd. Stephens reaffirmed an "overweight" rating and set a $240.00 target price on shares of STERIS in a research note on Thursday, February 6th. Finally, JMP Securities reissued a "market outperform" rating and issued a $265.00 price target on shares of STERIS in a research note on Thursday, February 6th. One investment analyst has rated the stock with a hold rating and five have issued a buy rating to the company's stock. According to data from MarketBeat.com, STERIS has a consensus rating of "Moderate Buy" and a consensus target price of $258.75.

Remove Ads

STERIS Stock Up 0.6 %

STE stock traded up $1.29 during trading on Thursday, reaching $224.35. 503,563 shares of the stock were exchanged, compared to its average volume of 503,714. The firm has a market cap of $22.04 billion, a P/E ratio of 47.63 and a beta of 0.92. STERIS plc has a twelve month low of $197.82 and a twelve month high of $248.24. The firm's 50 day moving average is $222.24 and its 200 day moving average is $221.63. The company has a current ratio of 2.13, a quick ratio of 1.40 and a debt-to-equity ratio of 0.32.

STERIS (NYSE:STE - Get Free Report) last posted its quarterly earnings results on Wednesday, February 5th. The medical equipment provider reported $2.32 earnings per share (EPS) for the quarter, missing the consensus estimate of $2.33 by ($0.01). STERIS had a net margin of 8.66% and a return on equity of 13.91%. As a group, research analysts forecast that STERIS plc will post 9.08 EPS for the current year.

STERIS Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Friday, March 21st. Stockholders of record on Thursday, February 20th were paid a $0.57 dividend. This represents a $2.28 annualized dividend and a dividend yield of 1.02%. The ex-dividend date was Thursday, February 20th. STERIS's dividend payout ratio (DPR) is presently 48.41%.

About STERIS

STERIS plc provides infection prevention products and services worldwide. It operates through four segments: Healthcare, Applied Sterilization Technologies, Life Sciences, and Dental. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; endoscopy accessories, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, and connectivity solutions, as well as equipment management services.